Premier Inc. and 11 Leading Health Systems Invest in Exela Pharma Sciences to Secure and Support U.S.-Based Drug Supply and Manufacturing
Drug shortages have long plagued U.S. healthcare providers; COVID-19 has compounded sourcing challenges. New initiative will manufacture pharmaceutical products in North Carolina, primarily using APIs from the U.S. and Europe Premier Inc., a technology-driven healthcare…